Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating CYP2D6 Genotype-Guided Tamoxifen Therapy for a Multiracial U.S. Population

NCT00764322 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT00764322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00764322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating CYP2D6 Genotype-Guided Tamoxifen Therapy for a Multiracial U.S. Population
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
June 18, 2008
Completion date
July 1, 2011
Enrollment
501 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, menopausal symptoms